Tom Lin

Biography

  Dr. Tom Lin graduated from The University of Sydney Medical School with a multi-disciplinary specialization in cardiology, neurology, immunology, and was awarded a PhD in Medicine for his research and development of immunotherapies in the treatment of autoimmune neuropathies. During his doctoral training, Dr. Lin was also awarded a fellowship at The University of Melbourne, where he completed his Specialist Certificate in Clinical Neuroscience, and trained under visiting professor, Dr. Barry Marshall (Nobel Laureate in Medicine) in clinical research and drug development.  Dr. Lin’s educational background also includes Clinical Scholars Program from Harvard Medical School and The Royal college of Physicians (London), and an Executive MBA and Global Chief Executive Program from Columbia University, London Business School, and Wharton Business School. Prior to founding Lin Bioscience, Dr. Lin has served as President, Chief Operations Officer, and Medical Director for biotech and pharmaceutical companies. Dr. Lin has a vast clinical and drug development experience in cardiovascular, oncology, immuno-oncology, autoimmune and anti-inflammatory therapeutic areas, and has a successful track record in taking biotech start-up companies to IPO.  

Research Interest

Clinical and drug development experience in cardiovascular, oncology, immuno-oncology, autoimmune and anti-inflammatory therapeutic areas, Pharmacology